Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
D. A. SMITH, S. M. ABEL, R. HYLAND & B. C. JONES. (1998) Human cytochrome P450s: selectivity and measurement in vivo. Xenobiotica 28:12, pages 1095-1128.
Read now
Read now
Sergey V. Geodakyan. (1993) Methodological Approach in the Study of Anticancer Drug Metabolism: Qualitative Considerations. Drug Metabolism Reviews 25:1-2, pages 153-172.
Read now
Read now
D. A. Smith, M. J. Humphrey & C. Charuel. (1990) Design of toxicokinetic studies. Xenobiotica 20:11, pages 1187-1199.
Read now
Read now
C. N. Manners, D. W. Payling & D. A. Smith. (1989) Lipophilicity of zwitterionic sulphate conjugates of tiaramide, propranolol and 4′-hydroxypropranolol. Xenobiotica 19:12, pages 1387-1397.
Read now
Read now
Articles from other publishers (37)
Yu-Ling Liu, Hui-Ju Huang, Sheh-Yi Sheu, Yu-Cheng Liu, I-Jung Lee, Shao-Chin Chiang & Anya Maan-Yuh Lin. (2023) Oral ellagic acid attenuated LPS-induced neuroinflammation in rat brain: MEK1 interaction and M2 microglial polarization. Experimental Biology and Medicine 248:7, pages 656-664.
Crossref
Crossref
Eddie Yang, Joseph W. Tucker, Thomas A. Chappie, John D. Weaver, Caroline Chapman, Remzi Duzguner & John M. Humphrey. (2023) Synthesis of a Pyridoazepine Scaffold via Rhodium-Catalyzed Ring Expansion and Nitroacetamide Condensation. Organic Process Research & Development 27:2, pages 248-255.
Crossref
Crossref
Marta Tikhomirov, Paweł Jajor, Tomasz Śniegocki & Błażej Poźniak. (2022) Predicting the efficacy of opioid sequestration by intravenous lipid emulsion using biologically relevant in vitro models of drug distribution. Scientific Reports 12:1.
Crossref
Crossref
Erkka Järvinen, Feng Deng, Wilma Kiander, Alli Sinokki, Heidi Kidron & Noora Sjöstedt. (2022) The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates. Frontiers in Pharmacology 12.
Crossref
Crossref
Hanna Barchanska, Rafał Rola, Wojciech Szczepankiewicz & Marta Mrachacz. (2019) LC-MS/MS study of the degradation processes of nitisinone and its by-products. Journal of Pharmaceutical and Biomedical Analysis 171, pages 15-21.
Crossref
Crossref
Cory L. Strope, Kamel Mansouri, Harvey J. ClewellIIIIII, James R. Rabinowitz, Caroline Stevens & John F. Wambaugh. (2018) High-throughput in-silico prediction of ionization equilibria for pharmacokinetic modeling. Science of The Total Environment 615, pages 150-160.
Crossref
Crossref
Dennis A. Smith. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology
53
66
.
Dennis A. SmithKevin Beaumont, Tristan S. Maurer & Li Di. (2015) Volume of Distribution in Drug Design. Journal of Medicinal Chemistry 58:15, pages 5691-5698.
Crossref
Crossref
Lindsay B. Avery, Jennifer L. VanAusdall, Craig W. Hendrix & Namandjé N. Bumpus. (2013) Compartmentalization and Antiviral Effect of Efavirenz Metabolites in Blood Plasma, Seminal Plasma, and Cerebrospinal Fluid. Drug Metabolism and Disposition 41:2, pages 422-429.
Crossref
Crossref
Alex Avdeef. 2012. Absorption and Drug Development. Absorption and Drug Development
174
219
.
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
1
17
.
Hong Yu, Ye Liu, Hong B Li, Arnold R Martin, Uli Hacksell & Tommy Lewander. (1997)
Pharmacodynamic and Pharmacokinetic Studies in Rats of
S
-8-(2-Furyl)- and
R
-8-Phenyl-2-(di-
n
-Propylamino)Tetralin, Two Novel 5-HT1A Receptor Agonists In-vitro with Different Properties In-vivo
. Journal of Pharmacy and Pharmacology 49:2, pages 169-177.
Crossref
Crossref
David Stopher & Siobhan McClean. (1990) An improved method for the determination of distribution coefficients. Journal of Pharmacy and Pharmacology 42:2, pages 144-144.
Crossref
Crossref
Alexander Böcker, Pierre R. Bonneau, Oliver Hucke, Araz Jakalian & Paul J. Edwards. (2010) Development of Specific “Drug-Like Property” Rules for Carboxylate-Containing Oral Drug Candidates. ChemMedChem 5:12, pages 2102-2113.
Crossref
Crossref
Dennis A SmithR Scott Obach. (2010) Metabolites: have we MIST out the importance of structure and physicochemistry?. Bioanalysis 2:7, pages 1223-1233.
Crossref
Crossref
Sophie Martel, Vincent Gasparik & Pierre‐Alain Carrupt. 2009. Hit and Lead Profiling. Hit and Lead Profiling
91
116
.
Takashi Mano. (2009) Pharmaceutical research in the early stages of drug discovery—significance and practice. Folia Pharmacologica Japonica 133:3, pages 149-153.
Crossref
Crossref
CHAD L. STONER, MATTHEW D. TROUTMAN & CAROLINE E. LAVERTY. 2008. Cancer Drug Design and Discovery. Cancer Drug Design and Discovery
131
153
.
C. Lindsay Devane, Zachary N. Stowe, Jennifer L. Donovan, D. Jeffrey Newport, Page B. Pennell, James C. Ritchie, Michael J. Owens & Jun-Sheng Wang. (2016) Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. Journal of Psychopharmacology 20:4_suppl, pages 54-59.
Crossref
Crossref
Rakesh Dixit. 2006. Biological Concepts and Techniques in Toxicology. Biological Concepts and Techniques in Toxicology
117
160
.
Takashi Mano, Yoshiyuki Okumura, Minoru Sakakibara, Takako Okumura, Tetsuya Tamura, Kimitaka Miyamoto & Rodney W. Stevens. (2003)
4-[5-Fluoro-3-[4-(2-methyl-1
H
-imidazol-1-yl)benzyloxy]phenyl]-3,4,5,6- tetrahydro-2
H
-pyran-4-carboxamide, an Orally Active Inhibitor of 5-Lipoxygenase with Improved Pharmacokinetic and Toxicology Characteristics
. Journal of Medicinal Chemistry 47:3, pages 720-725.
Crossref
Crossref
Alekha K Dash & William F Elmquist. (2003) Separation methods that are capable of revealing blood–brain barrier permeability. Journal of Chromatography B 797:1-2, pages 241-254.
Crossref
Crossref
Michael H Tarbit & Judd Berman. (1998) High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds. Current Opinion in Chemical Biology 2:3, pages 411-416.
Crossref
Crossref
P.O Erah, D.A Barrett & P.N Shaw. (1998) Reversed-phase high-performance liquid chromatographic assay methods for the analysis of a range of penicillins in in vitro permeation studies. Journal of Chromatography B: Biomedical Sciences and Applications 705:1, pages 63-69.
Crossref
Crossref
Alessandra Pagliara, Pierre-Alain Carrupt, Giulia Caron, Patrick Gaillard & Bernard Testa. (1997) Lipophilicity Profiles of Ampholytes. Chemical Reviews 97:8, pages 3385-3400.
Crossref
Crossref
Hong Yu & Tommy Lewander. (1997) Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. European Neuropsychopharmacology 7:3, pages 165-172.
Crossref
Crossref
Giulia Caron, Patrick Gaillard, Pierre‐Alain Carrupt & Bernard Testa. (2004) Lipophilicity Behavior of Model and Medicinal Compounds containing a suilfide, sulfoxide, or sulfone moiety. Helvetica Chimica Acta 80:2, pages 449-462.
Crossref
Crossref
Beate I. Escher & René P. Schwarzenbach. (1995) Partitioning of Substituted Phenols in Liposome−Water, Biomembrane−Water, and Octanol−Water Systems. Environmental Science & Technology 30:1, pages 260-270.
Crossref
Crossref
B. Walther, P. Vis & A. Taylor. 1996. Lipophilicity in Drug Action and Toxicology. Lipophilicity in Drug Action and Toxicology
253
261
.
Ove A. Nedergaard. (2009) Effect of Dopexamine Hydrochloride on Sympathetic Neuroeffector Transmission in Rabbit Isolated Pulmonary Artery. Pharmacology & Toxicology 78:3, pages 161-166.
Crossref
Crossref
KONRAD F. KOEHLER, SHASHIDHAR N. RAO & JAMES P. SNYDER. 1996. Guidebook on Molecular Modeling in Drug Design. Guidebook on Molecular Modeling in Drug Design
235
336
.
Dennis A. Smith. (1994) Chemistry and enzymology: Their use in the prediction of human drug metabolism. European Journal of Pharmaceutical Sciences 2:1-2, pages 69-71.
Crossref
Crossref
Dennis A. Smith. (1994) Design of drugs through a consideration of drug metabolism and pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics 19:3, pages 193-199.
Crossref
Crossref
John R. Bantick, Haydn G. Beaton, Sally L. Cooper, Stephen Hill, Simon C. Hirst, Thomas McInally, Jane Spencer, Alan C. Tinker & Paul A. Willis. (1994) New non-peptide angiotensin II receptor antagonists. 1: structure - activity relationships of a series of a series of 2(1H)-pyridinones.. Bioorganic & Medicinal Chemistry Letters 4:1, pages 121-126.
Crossref
Crossref
Robert L. Lipnick & Vladimir A. Filov. (1992) Nikolai Vasilyevich Lazarev, toxicologist and pharmacologist, comes in from the cold. Trends in Pharmacological Sciences 13, pages 56-60.
Crossref
Crossref
R.H. Böcker, R. Peter, G. Machbert & W. Bauer. (1991) Identification and determination of the two principal metabolites of minocycline in humans. Journal of Chromatography B: Biomedical Sciences and Applications 568:2, pages 363-374.
Crossref
Crossref
Ruey-Shiuan Tsai, Bernard Testa, Nabil El Tayar & Pierre-Alain Carrupt. (1991) Structure–lipophilicity relationships of zwitterionic amino acids. J. Chem. Soc., Perkin Trans. 2:11, pages 1797-1802.
Crossref
Crossref